原发性人类皮肤恶性黑色素瘤的组织发生及生物学行为 - Suppr

Suppr

超能文献

The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

作者信息

Clark W H, From L, Bernardino E A, Mihm M C

出版信息

Cancer Res. 1969 Mar;29(3):705-27.

PMID:5773814

Abstract

摘要

相似文献

The histogenesis and biologic behavior of primary human malignant melanomas of the skin.原发性人类皮肤恶性黑色素瘤的组织发生及生物学行为

Cancer Res. 1969 Mar;29(3):705-27.

The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas.皮肤恶性黑色素瘤早期阶段的临床诊断、分类及组织发生学概念。

N Engl J Med. 1971 May 13;284(19):1078-82. doi: 10.1056/NEJM197105132841907.

[Multiple primary malignant melanomas. A report of five cases (author's transl)].[多发性原发性恶性黑色素瘤。5例报告（作者译）]

Sem Hop. 1979;55(27-30):1312-6.

[Case of Spitz cellular nevus observed during its malignant transformation].[在恶性转化过程中观察到的斯皮茨细胞痣病例]

Wiad Lek. 1974 Aug 1;27(15):1413-4.

[New classification of malignant melanoma. Basic concepts and practical significance].[恶性黑色素瘤的新分类。基本概念与实际意义]

Med Klin. 1976 Oct 8;71(41):1707-15.

[Autonomous nevocytoma. Etiology and pathology of melanohistoma].[自主性痣细胞瘤。黑色素组织细胞瘤的病因学与病理学]

Hautarzt. 1970 Jun;21(6):252-8.

Metastatic malignant melanoma in prepubertal children.青春期前儿童的转移性恶性黑色素瘤。

Pediatrics. 1975 Feb;55(2):191-204.

Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.与获得性黑素细胞痣相关的恶性黑色素瘤预后良好。

Arch Dermatol. 1983 Jun;119(6):455-62.

[Diagnostic characteristics of malignant melanomas and pigmented nevi with a tendency to develop into melanomas].[恶性黑色素瘤及有发展为黑色素瘤倾向的色素痣的诊断特征]

Dtsch Med Wochenschr. 1987 Apr 3;112(14):551-2. doi: 10.1055/s-2008-1068095.

[Comparative clinical and histological investigations on malignant melanomas of the skin (author's transl)].皮肤恶性黑色素瘤的比较临床与组织学研究（作者译）

Dermatol Monatsschr. 1980 Aug;166(8):531-40.

引用本文的文献

IgSF11-RAP1 signaling promotes cell migration and invasion of cutaneous melanoma.IgSF11-RAP1信号传导促进皮肤黑色素瘤的细胞迁移和侵袭。

Cell Commun Signal. 2025 Jul 10;23(1):330. doi: 10.1186/s12964-025-02245-5.

Tumor-Infiltrating Lymphocyte Therapy for the Treatment of Metastatic Melanoma.肿瘤浸润淋巴细胞疗法治疗转移性黑色素瘤

Am J Clin Dermatol. 2025 Jun 23. doi: 10.1007/s40257-025-00957-5.

Enantiomeric Excess Bupivacaine in a Lavender Oil NLC Tested in a Melanoma Model: Prolonged Release and Anticancer Effect.在黑色素瘤模型中测试的薰衣草油纳米脂质载体中的对映体过量布比卡因：缓释与抗癌作用

Mol Pharm. 2025 Jun 2;22(6):3351-3365. doi: 10.1021/acs.molpharmaceut.5c00254. Epub 2025 May 1.

HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic.组蛋白去乙酰化酶/σ1受体双配体作为靶向性黑色素瘤治疗药物

Pharmaceuticals (Basel). 2025 Jan 28;18(2):179. doi: 10.3390/ph18020179.

The relationship between depth of invasion and cervical lymph node metastasis in patients with laryngeal squamous cell carcinoma.喉鳞状细胞癌患者的浸润深度与颈部淋巴结转移之间的关系。

Eur Arch Otorhinolaryngol. 2025 Mar;282(3):1375-1379. doi: 10.1007/s00405-025-09215-0. Epub 2025 Feb 6.

Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.端粒、端粒酶与癌症：作用机制、生物标志物及治疗方法

Exp Hematol Oncol. 2025 Jan 27;14(1):8. doi: 10.1186/s40164-025-00597-9.

Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.儿童癌症成年幸存者中的黑色素瘤：来自儿童癌症幸存者研究的报告。

J Clin Oncol. 2025 Apr;43(10):1219-1228. doi: 10.1200/JCO-24-01519. Epub 2025 Jan 8.

Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells.利用免疫组化染色免疫细胞的自动化图像定量分析对原发性三阴性乳腺癌的肿瘤免疫特征进行分析。

Sci Rep. 2024 Sep 13;14(1):21417. doi: 10.1038/s41598-024-72306-1.

Unaddressed Challenges in the Treatment of Cutaneous Melanoma?未解决的皮肤黑素瘤治疗挑战？

Medicina (Kaunas). 2024 May 28;60(6):884. doi: 10.3390/medicina60060884.

Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling.恶性黑色素瘤：概述、新观点及维生素D信号传导

Cancers (Basel). 2024 Jun 18;16(12):2262. doi: 10.3390/cancers16122262.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验